From May 7, 2022 to May 8, 2022, all the members of Beimei went to Dapeng, a beautiful seaside town in Shenzhen, to carry out the team building activity, aiming to promote team communication, enhance team collaboration and team cohesion, to build an excellent team of unity, cooperation and enterprising.

Beimei Pharma’sseries B/ B+ financing roundFollowing the completion of the Series A round financing in January 2021, Shenzhen Beimei Pharmaceutical Co., Ltd. (hereinafter referred to as "Beimei Pharma") has recently completed the Series B and B+ financing. Led by Efung Investment Management, followed by Acer Capital, Lianrun Oriental, Hainan Jinbei and other ...

Shenzhen Beimei Pharmaceutical Co., LTD. (hereinafter referred to as "Beimei Pharmaceutical") has officially received the acceptance letter issued by the Drug Evaluation Center of the National Medical Products Administration.The sevelamercarbonate powder for oral suspension, which isimportedby Beimei Pharmaceutical,its application was accepted.In March 2022, Beimei ...

On April 1, 2022, Shenzhen Beimei Pharmaceutical Co., Ltd. (hereinafter referred to as "Beimei Pharmaceutical") and Netherlands Synthon B.V. (hereinafter referred to as " Synthon ") reached an exclusive license and supply agreement of a pharmaceutical product for the treatment of hyperphosphatemia (hereinafter referred to as "the product"). Under the te...

The soft wind in early spring brings the most beautiful goddess Festival. On the morning of March 8, President Wu shared with all the fairies of the company how professional women balance work and life.To be a better self, not only shine today!Wish all female friends a happy holiday, healthy and beautiful!

On February 24, 2022, Shenzhen Beimei Pharmaceutical Co., Ltd. (hereinafter referred to as "Beimei Pharmaceutical") and Dr. Reddy'slaboratory Ltd. (hereinafter referred to as "Dr. Reddy's") reached an exclusive license and supply agreement of a pharmaceutical product for the treatment of otic infection (hereinafter referred to as "the product"). ...

When the Christmas tree shines, when the bells jingle at the end of the year, the beauty and tenderness will come as promised.In this romantic winter day, the company prepared a warm Christmas-themed afternoon tea and staff birthday party.There are desserts, fruits, snacks, juices, drinks, full of Christmas rituals.Each oneof Bemei can draw a small Christmas gift prepared by the company, ...

Shenzhen Beimei Pharmaceutical Co., Ltd. and MedPharm Ltd. (hereinafter referred to as "MedPharm") signed the Master Service Agreement (hereinafter referred to as the "Agreement") on 15th, Nov, 2021. According to the agreement, Beimei and MedPharm will cooperate in the development of a topical product for the treatment of immune diseases. MedPharm will be responsible for the preclinical research and development of products and technology transfer and will provide technical support for patent applications and product registrations. Beimei will have the exclusive right to commercialize the product in the global region, and will be responsible for the clinical study, registration, sales and promotion of the product and other commercialization activities.

Generic name:Atomoxetine Hydrochloride Oral SolutionDosage form:Oral SolutionRegistration category: Class 4The first self-developed product of Beimei, Atomoxetine Hydrochloride Oral Solution, with its dossier completion of pharmacological studies and registration data, has been filed to the Center for Drug Evaluation (CDE) of the National Medical Products Administration o...